EBNA2 mediates lipid metabolism and tumorigenesis through activation of ATF4 pathway.
Jia Feng, Ping Zhang, Paul Yao

и другие.

PubMed, Год журнала: 2023, Номер 13(4), С. 1363 - 1376

Опубликована: Янв. 1, 2023

Epstein-Barr virus (EBV) can infect the majority of human population with no obvious symptoms and is associated tumor development, although mechanism still largely unknown. In this study, we investigated role underlying EBV nuclear antigen 2 (EBNA2) in tumorigenesis. We found that infection EBNA2 B lymphocytes (HBL) upregulated expression activating transcription factor 4 (ATF4). Furthermore, used gene or knockdown approach to demonstrate effect on redox balance, mitochondrial function, lipid metabolism, cell proliferation both HBL EBV-transformed lymphocyte line (LCL). More importantly, applied vivo xenograft mouse model explore contribution ATF4 growth survival. Mechanistically, revealed exposure caused persistent via EBNA2-mediated epigenetic changes, which increased binding ability upstream stimulating 1 (USF1) promoter. activation cells modulated metabolism-related genes potentiated fatty acid oxidation lipogenesis. Conversely, either LCL suppressed balance as well inhibited proliferation. consistent these findings from vitro an confirmed SREBP1, ChREBP, FAS, prolonged animal Collectively, study demonstrates mediates tumorigenesis through modulation metabolism; therefore, our provide a novel avenue for clinical treatment EBV-mediated cancer.

Язык: Английский

ATF4 in cellular stress, ferroptosis, and cancer DOI
Hu Tang, Rui Kang, Jiao Liu

и другие.

Archives of Toxicology, Год журнала: 2024, Номер 98(4), С. 1025 - 1041

Опубликована: Фев. 21, 2024

Язык: Английский

Процитировано

25

Interactions between oxidative stress and senescence in cancer: Mechanisms, therapeutic implications, and future perspectives DOI Creative Commons
Dengxiong Li, Qingxin Yu,

Ruicheng Wu

и другие.

Redox Biology, Год журнала: 2024, Номер 73, С. 103208 - 103208

Опубликована: Май 24, 2024

Recently, numerous studies have reported the interaction between senescence and oxidative stress in cancer. However, there is a lack of comprehensive understanding precise mechanisms involved.

Язык: Английский

Процитировано

20

STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma DOI Creative Commons
Kan Jiang, Xin Yin,

Qingyi Zhang

и другие.

Redox Biology, Год журнала: 2023, Номер 60, С. 102626 - 102626

Опубликована: Фев. 2, 2023

Radioresistance is the major reason for failure of radiotherapy in esophageal squamous cell carcinoma (ESCC). Previous evidence indicated that stanniocalcin 2 (STC2) participates various biological processes malignant tumors. However, researches on its effect radioresistance cancers are limited. In this study, STC2 was screened out by RNA-sequencing and bioinformatics analyses as a potential prognosis predictor ESCC radiosensitivity then determined to facilitate radioresistance. We found expression increased tissues compared adjacent normal tissues, higher level associated with poor prognosis. Also, mRNA protein levels were radioresistant cells than their parental cells. Further investigation revealed could interact methyltransferase 5 (PRMT5) activate PRMT5, thus leading symmetric dimethylation histone H4 Arg 3 (H4R3me2s). Mechanistically, can promote DDR through homologous recombination non-homologous end joining pathways activating PRMT5. Meanwhile, participate SLC7A11-mediated ferroptosis PRMT5-dependent manner. Finally, these results validated vivo experiments. These findings uncovered might be an attractive therapeutic target overcome

Язык: Английский

Процитировано

37

Emerging mechanisms of the unfolded protein response in therapeutic resistance: from chemotherapy to Immunotherapy DOI Creative Commons
He Jiang, You Zhou, Lun‐Quan Sun

и другие.

Cell Communication and Signaling, Год журнала: 2024, Номер 22(1)

Опубликована: Янв. 31, 2024

The accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) causes ER stress and activates protein response (UPR). As an adaptive cellular to hostile microenvironments, such as hypoxia, nutrient deprivation, oxidative stress, chemotherapeutic drugs, UPR is activated diverse cancer types functions a dynamic tumour promoter development; this role indicates that regulation can be utilized target for treatment. T-cell exhaustion mainly refers effector T cells losing their expressing inhibitory receptors, leading immune evasion loss control. Emerging evidence suggests plays crucial exhaustion, evasion, resistance immunotherapy. In review, we summarize molecular basis activation, effect on emerging mechanisms chemotherapy immunotherapy resistance, agents therapeutics. An understanding therapeutic will helpful identify new modalities Video Abstract.

Язык: Английский

Процитировано

12

The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality DOI Creative Commons
C. M. Bray, Cristina Balcells, Iain A. McNeish

и другие.

Frontiers in Oncology, Год журнала: 2023, Номер 13

Опубликована: Сен. 19, 2023

Approximately 15% of cancers exhibit loss the chromosomal locus 9p21.3 – genomic location tumour suppressor gene CDKN2A and methionine salvage methylthioadenosine phosphorylase ( MTAP ). A increases pool its substrate (MTA), which binds to inhibits activity protein arginine methyltransferase 5 (PRMT5). PRMT5 utilises universal methyl donor S-adenosylmethionine (SAM) methylate residues substrates regulate their activity, notably histones transcription. Recently, targeting PRMT5, or MAT2A that impacts by producing SAM, has shown promise as a therapeutic strategy in oncology, generating synthetic lethality -negative cancers. However, clinical development inhibitors been challenging highlights need for further understanding downstream mediators drug effects. Here, we discuss rationale methods MAT2A/PRMT5 axis cancer therapy. We evaluate current limitations our mechanism identify challenges must be addressed maximise potential these drugs. In addition, review literature defining effectors could determine sensitivity inhibition therefore present novel combination therapies may not rely on with loss.

Язык: Английский

Процитировано

17

Epigenetic Regulation of Acute Lymphoblastic Leukemia DOI

香凝 罗

Advances in Clinical Medicine, Год журнала: 2025, Номер 15(01), С. 642 - 651

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

0

Protein Arginine Methyltransferases as Therapeutic Targets in Hematological Malignancies DOI Open Access
Camille Sauter,

John Simonet,

Fabien Guidez

и другие.

Cancers, Год журнала: 2022, Номер 14(21), С. 5443 - 5443

Опубликована: Ноя. 5, 2022

Arginine methylation is a common post-translational modification affecting protein activity and the transcription of target genes when occurs on histone tails. There are nine arginine methyltransferases (PRMTs) in mammals, divided into subgroups depending they form molecule arginine. During formation maturation different types blood cells, PRMTs play central role by controlling cell differentiation at transcriptional level. PRMT enzymatic necessary for many cellular processes hematological malignancies, such as activation cycle proliferation, inhibition apoptosis, DNA repair processes, RNA splicing, methylating tails’ Chemical tools have been developed to inhibit tested several models including primary samples from patients, xenografts immunodeficient mice, mouse models, human lines. They show significant effect reducing viability increasing overall survival mice. PRMT5 inhibitors strong therapeutic potential, phase I clinical trials malignancies that use these molecules promising results, thus, underlining useful cancer treatment future.

Язык: Английский

Процитировано

22

ALKBH3-mediated m1A demethylation promotes the malignant progression of acute myeloid leukemia by regulating ferroptosis through the upregulation of ATF4 expression DOI Creative Commons
Xin Liu, Xinghua Pan

Hematology, Год журнала: 2025, Номер 30(1)

Опубликована: Янв. 13, 2025

To investigate the role of ALKBH3 in acute myeloid leukemia (AML), we constructed an animal model xenotransplantation AML. Our study demonstrated that ALKBH3-mediated m1A demethylation inhibits ferroptosis KG-1 cells by increasing ATF4 expression, thus promoting development These findings suggest reducing expression may be a potential strategy to mitigate AML progression.

Язык: Английский

Процитировано

0

PLK3 weakens antioxidant defense and inhibits proliferation of porcine Leydig cells under oxidative stress DOI Creative Commons
Chujie Chen, Jinyan He, Weixian Huang

и другие.

Scientific Reports, Год журнала: 2025, Номер 15(1)

Опубликована: Янв. 21, 2025

Aging is characterized by cellular degeneration and impaired physiological functions, leading to a decline in male sexual desire reproductive capacity. Oxidative stress (OS) lead testicular aging impairing the system, but potential mechanisms remain unclear. In present study, functional status of tissues from young aged boars was compared, transcriptional responses Leydig cells (LCs) hydrogen peroxide (H2O2)-induced senescence were explored, revealing role OS promoting system. 601 differentially expressed genes (DEGs) associated with OS, cell cycle regulation, intracellular processes identified. These DEGs significantly enriched critical pathways, including p53 signaling pathway, autophagy, senescence. Protein-protein interaction (PPI) network analysis unveiled 15 key related DNA replication, polo-like kinase 3 (PLK3) exhibiting increased expression under OS. vitro, PLK3 knockdown enhanced viability antioxidant capacity LCs This study deepens our understanding how respond provides new therapeutic targets for enhancing resistance oxidative damage tissue health.

Язык: Английский

Процитировано

0

Dexmedetomidine plays a protective role in sepsis-associated myocardial injury by repressing PRMT5-mediated ferroptosis. DOI
Dan Wang, Jun Wang, Li Yang

и другие.

PubMed, Год журнала: 2025, Номер 14(1), С. tfaf010 - tfaf010

Опубликована: Фев. 1, 2025

Sepsis rapidly contributed to multiorgan failure, most typically damaging the cardiovascular system, and there were no effective treatments. Dexmedetomidine (Dex) has good therapeutic effects on sepsis-induced organ injury. Our work aimed probe pharmacological of Dex ferroptosis in sepsis-associated myocardial injury (S-MI) define underlying mechanism action. Cardiomyocytes exposed lipopolysaccharide (LPS) for mimicking S-MI model vitro. The septic mice constructed by cecum ligation puncture operation. mRNA protein expressions assessed using quantitative real-time polymerase chain reaction or western blot. Cell survival was determined cell counting kit-8, lactic dehydrogenase release, flow cytometry assays. 2',7'-Dichlorodihydrofluorescein diacetate staining measured cellular reactive oxygen species level. secretion levels inflammatory cytokines, ferroptosis-related indicators analyzed enzyme-linked immunosorbent assay. N6-methyladenosine (m6A) modification level arginine methyltransferase 5 (PRMT5) examined methylated RNA binding immunoprecipitation (Me-RIP) interaction between like 3 (METTL3)/fat mass obesity-associated (FTO) PRMT5 treatment alleviated LPS-induced cardiomyocyte ferroptosis, while these reversed Erastin treatment. Mechanically, ameliorated expression cardiomyocytes regulating METTL3/FTO catalyzed m6A mRNA. Rescue experiments confirmed that overexpression abolished Dex-mediated inhibitory roles ferroptosis. Moreover, administration inflammation, mice. Taken together, repressed PMRT5 a m6A-dependent manner, thus lightening LPS-triggered alleviate

Язык: Английский

Процитировано

0